Our research identifies NeuroD1 as a potential therapeutic target for pancreatic cancer and suggests that pancreatic tumor cells can be induced to revert to a normal or a normal-like state through gene editing or through the use of agents that induce cell differentiation, suggesting a new direction for the treatment of pancreatic cancer. The gene discussed is NEUROD1; the disease is pancreatic neoplasm.